The effect of insulin degludec in combination with liraglutide and metformin in patients with type 2 diabetes requiring treatment intensification

被引：0
作者：
Aroda, V. R. [1 ]
Bailey, T. [2 ]
Cariou, B. [3 ]
Kumar, S. [4 ,5 ]
Leiter, L. A. [6 ]
Raskin, P. [7 ]
Zacho, J. [8 ]
Bandier, M. [8 ]
Philis-Tsimikas, A. [9 ]
机构：
[1] MedStar Hlth Res Inst, Hyattsville, MD USA
[2] AMCR Inst Inc, Escondido, CA USA
[3] Nantes Univ Hosp, Dept Endocrinol, Nantes, France
[4] Univ Hosp Coventry, WISDEM Ctr, Coventry, W Midlands, England
[5] Univ Hosp Warwickshire, WISDEM Ctr, Coventry, W Midlands, England
[6] Univ Toronto, St Michaels Hosp, Toronto, ON M5S 1A1, Canada
[7] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[8] Novo Nordisk AS, Soborg, Denmark
[9] Scripps Whittier Diabet Inst, San Diego, CA USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
145
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
[41]   An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin [J].
Evans, Marc ;
Billings, Liana K. ;
Hakan-Bloch, Jonas ;
Slothuus, Ulla ;
Abrahamsen, Trine J. ;
Andersen, Andreas ;
Jansen, Jeroen P. .
JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (04) :340-347
[42]   Improved postprandial glycaemic control in Type 2 diabetes with a combination of insulin degludec and liraglutide: results from a meal test [J].
Gough, S. C. L. ;
Rodbard, H. W. ;
Woo, V. C. ;
Linjawi, S. ;
Poulsen, P. ;
Damgaard, L. ;
Bode, B. W. .
DIABETIC MEDICINE, 2014, 31 :61-61
[43]   Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden [J].
Åsa Ericsson ;
Adam Lundqvist .
Applied Health Economics and Health Policy, 2017, 15 :237-248
[44]   Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden [J].
Ericsson, Asa ;
Lundqvist, Adam .
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2017, 15 (02) :237-248
[45]   Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes [J].
Haak, Thomas .
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2015, 8 :1-6
[46]   Insulin degludec/liraglutide: innovation-driven combination for advancement in diabetes therapy [J].
Kumar, Ajay .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (06) :869-878
[47]   Cost-effectiveness analysis of insulin degludec/liraglutide (IDegLira) vs other basal insulin intensification strategies in Type 2 diabetes patients uncontrolled on basal insulin in a UK setting [J].
Davies, M. ;
McEwan, P. ;
Glah, D. ;
Chubb, B. ;
Konidaris, G. ;
Iversen, P. .
DIABETIC MEDICINE, 2016, 33 :155-155
[48]   In patients with type 2 diabetes, overall treatment satisfaction improves following a switch from sitagliptin to liraglutide treatment in combination with metformin [J].
Montanya Mias, E. ;
Pratley, R. ;
Nauck, M. A. ;
Bailey, T. ;
Garber, A. ;
Filetti, S. ;
Thomsen, A. B. ;
Hammer, M. ;
Davies, M. .
DIABETOLOGIA, 2011, 54 :S322-S323
[49]   Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets [J].
DeVries, J. Hans ;
Bain, Stephen C. ;
Rodbard, Helena W. ;
Seufert, Jochen ;
D'Alessio, David ;
Thomsen, Anne B. ;
Zychma, Marcin ;
Rosenstock, Julio .
DIABETES CARE, 2012, 35 (07) :1446-1454
[50]   Can a fixed-ratio combination of insulin degludec and liraglutide help Type 2 diabetes patients to optimize glycemic control across the day? [J].
Simpson, Richard ;
King, Allen .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (02) :179-188
12345